Atıf İçin Kopyala
DEMİR ÖZKAY Ü., CAN Ö. D., SAĞLIK B. N., Turan N.
PHARMACOLOGICAL REPORTS, cilt.69, sa.6, ss.1349-1356, 2017 (SCI-Expanded)
-
Yayın Türü:
Makale / Tam Makale
-
Cilt numarası:
69
Sayı:
6
-
Basım Tarihi:
2017
-
Doi Numarası:
10.1016/j.pharep.2017.06.009
-
Dergi Adı:
PHARMACOLOGICAL REPORTS
-
Derginin Tarandığı İndeksler:
Science Citation Index Expanded (SCI-EXPANDED), Scopus
-
Sayfa Sayıları:
ss.1349-1356
-
Anahtar Kelimeler:
Acetylcholinesterase, Molecular docking, Elevated plus maze test, Morris water maze test, Active avoidance test, GAMMA-SECRETASE INHIBITORS, POTENTIAL ANTIDEMENTIA DRUG, N-ARYLSULFONYL PIPERIDINES, ALZHEIMERS-DISEASE, INTRACEREBROVENTRICULAR STREPTOZOTOCIN, OXIDATIVE STRESS, CHOLINESTERASE ACTIVITY, INDUCED NEUROTOXICITY, AMYLOID AGGREGATION, MEMORY IMPAIRMENT
-
Anadolu Üniversitesi Adresli:
Evet
Özet
Background: Acetylcholinesterase (AChE) inhibitors are frequently prescribed to mitigate the cognitive decline in Alzheimer's disease. Thus, we investigated the possible efficacy of the AChE inhibitor 2-[(6-Nitro-2-benzothiazolyl) amino]-2-oxoethyl4-[2-(N, N-dimethylamino) ethyl] piperazine-1 carbodithioate (BPCT) in a streptozotocin (STZ)-induced Alzheimer's disease model (SADM).